Physician profile
Kayla Mapps
NPI 1871883199
$9,387.01
in general payments reported to CMS, 2019-2025
50 companies · $777 in 2025
The $777 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $625 · 2020: $98.78 · 2021: $289 · 2022: $922 · 2023: $6,042 · 2024: $634 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,585 · Food and Beverage: $2,463 · Travel and Lodging: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,584.99 |
| Food and Beverage | $2,463.07 |
| Travel and Lodging | $404.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,904.47 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $740.90 | 2019-2024 | |
| Astellas Pharma US INC | $371.38 | 2023-2025 | Veozah |
| Novo Nordisk INC | $316.79 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Mayne Pharma Commercial LLC | $284.87 | 2021-2025 | |
| Hologic Sales and Service, LLC | $217.69 | 2019-2025 | Aptima, Acessa Provu System, Coolseal Generator |
| Abbott Laboratories | $180.97 | 2023-2025 | Freestyle Libre 3, Proclaim |
| Pfizer INC. | $173.30 | 2019-2024 | |
| Integra Lifesciences Corporation | $170.09 | 2022-2023 | Biodoptix, Biofix, Medihoney |
| Therapeuticsmd, INC. | $149.66 | 2019 | |
| Organon LLC | $136.08 | 2022-2025 | Nexplanon |
| Lilly USA, LLC | $135.91 | 2022-2024 | Mounjaro, Jardiance, Zepbound |
| Biohaven Pharmaceutical Holding Company LTD. | $128.32 | 2022 | |
| Sage Therapeutics, LLC | $99.80 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $76.28 | 2019-2023 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Mapps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.